Form D · Biotechnology
Mongoose Bio, Inc.
Houston, TX · CIK 0001998401
Offering snapshot reported Oct 24, 2023 · SEC filing
- Reported sold
- $1M Offering amount: $3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 12, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 24, 2023 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-495492
Source: Form D, filed Oct 24, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Norman Michael Greenberg | Director, Executive, Promoter |
| Peter Hoang | Director, Promoter |
| Shailbala Singh | Executive, Promoter |
| Cassian Yee | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
609 Main Street Suite 4200
Houston, TX, 77002
Houston, TX, 77002